Evidence map›Paper›PMID 33998070›Full record

ArticleChemistry (Weinheim an der Bergstrasse, Germany)2021

Preparation of Butadienylpyridines by Iridium-NHC-Catalyzed Alkyne Hydroalkenylation and Quinolizine Rearrangement.

Ramón Azpíroz, Ingo Greger, Luis A Oro, Vincenzo Passarelli, Ricardo Castarlenas, Jesús J Pérez-Torrente

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ramón AzpírozDepartamento de Química Inorgánica Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, 50009, Zaragoza, Spain.ORCID http://orcid.org/0000-0002-0096-1560
Ingo GregerDepartamento de Química Inorgánica Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, 50009, Zaragoza, Spain.
Luis A OroDepartamento de Química Inorgánica Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, 50009, Zaragoza, Spain.ORCID http://orcid.org/0000-0001-7154-7239
Vincenzo PassarelliDepartamento de Química Inorgánica Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, 50009, Zaragoza, Spain.ORCID http://orcid.org/0000-0002-1735-6439
Ricardo CastarlenasDepartamento de Química Inorgánica Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, 50009, Zaragoza, Spain.ORCID http://orcid.org/0000-0003-4460-8678
Jesús J Pérez-TorrenteDepartamento de Química Inorgánica Instituto de Síntesis Química y Catálisis Homogénea-ISQCH, Universidad de Zaragoza-CSIC, Facultad de Ciencias, 50009, Zaragoza, Spain.ORCID http://orcid.org/0000-0002-3327-0918

Funding

Departamento de Ciencia, Universidad y Sociedad del Conocimiento del Gobierno de Aragón Group E42_20RHumboldt FoundationMICINN/FEDER PID2019-103965GB-I00
6 · The paper itself

Abstract

Iridium(I) N-heterocyclic carbene complexes of formula Ir(κ

Indexed as

catalysisC−C couplingC−H activationhydroalkenylationiridiumN-heterocyclic carbenes

Identifiers

PMID33998070
PMCPMC8453560

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.